Acadia Pharmaceuticals ACAD Gain (Loss) on Disposition of Other Assets
Gain (Loss) on Disposition of Other Assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.
The official record: Acadia Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's gain (loss) on disposition of other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's gain (loss) on disposition of other assets?
- Acadia Pharmaceuticals (ACAD) reported gain (loss) on disposition of other assets of $0 in Q4 2025.
- How has Acadia Pharmaceuticals's gain (loss) on disposition of other assets changed year-over-year?
- Acadia Pharmaceuticals's gain (loss) on disposition of other assets decreased by 100.0% year-over-year, from $36.63M to $0.